Pfizer's (PFE) Bosutinib Misses Endpoint in Phase 3 Versus Imatinib

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/14/2026

1. IBM
2. JPM
3. TREX
4. BAC
5. SPY
6. WFC
7. ERAS
8. SPRO
9. TSCO
10. AAPL

Go back to Pfizer's (PFE) Bosutinib Misses Endpoint in Phase 3 Versus Imatinib
Pfizer Inc. (NYSE: PFE) Delayed: 24.48 --0 (-0%)
Previous Close $24.48    52 Week High $37.39 
Open $24.48    52 Week Low $28.25 
Day High $24.48    P/E 14.84 
Day Low $24.48    EPS $1.65 
Volume 152,037